Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An announcement from Olympus ( (JP:7733) ) is now available.
Olympus Corporation reported a significant increase in operating profit for the fiscal year ended March 31, 2025, despite a decline in total comprehensive income. The company has classified its Orthopedic Business as a discontinued operation, impacting the financial results. The forecast for the next fiscal year indicates a slight increase in revenue, but a decrease in operating profit and profit attributable to owners. The company also announced changes in its consolidation scope, including the addition of Olympus Corporation Chile and the exclusion of two other companies.
The most recent analyst rating on (JP:7733) stock is a Hold with a Yen2600.00 price target. To see the full list of analyst forecasts on Olympus stock, see the JP:7733 Stock Forecast page.
More about Olympus
Olympus Corporation is a prominent player in the medical technology industry, primarily focusing on the development and manufacturing of optical and digital solutions. The company is listed on the Prime Market of the Tokyo Stock Exchange and is known for its innovative products in medical, scientific, and industrial fields.
Average Trading Volume: 5,012,077
Technical Sentiment Signal: Sell
Current Market Cap: Yen2226.2B
Learn more about 7733 stock on TipRanks’ Stock Analysis page.